Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine

Condition:   Norovirus Infections Interventions:   Biological: VXA-GI.1.NN;   Biological: Placebo Tablet Sponsor:   Vaxart Recruiting

Source: ClinicalTrials.gov - April 22, 2021 Category: Research Source Type: clinical trials